What is considered a notable family history for meningioma?

Notable Family History for Meningioma

A family history of meningioma in first-degree relatives (parents, siblings, children) is considered notable and warrants heightened clinical attention, particularly when the patient presents at a young age (<25-30 years) or when multiple family members are affected. 1

Key Clinical Thresholds

Age-Based Considerations

• Meningioma diagnosed at <25 years should prompt consideration of genetic counseling and germline testing, regardless of family history 2
• Young age of onset combined with family history significantly increases suspicion for hereditary cancer predisposition syndromes 1

Family History Patterns That Are Notable

First-degree relatives (parents, siblings, children):

• Any first-degree relative with meningioma increases risk approximately 4-fold (OR 4.4) 3
• The association is even stronger in younger cases 3
• Multiple first-degree relatives with meningioma is highly significant 3

Second-degree relatives (grandparents, aunts/uncles, nieces/nephews, grandchildren, half-siblings):

• Should be documented but carry less weight than first-degree relatives 4

Associated Syndromic Features to Assess

When evaluating family history, specifically inquire about:

• Neurofibromatosis Type 2 (NF2): 20-40% of pediatric meningiomas occur in NF2 patients 5

  • Family history of bilateral vestibular schwannomas
  • Multiple meningiomas in family members
  • Other schwannomas, gliomas, or posterior subcapsular cataracts 2

• Other tumors suggesting hereditary syndromes:

  • Melanoma (OR 4.2 for meningioma risk) 6
  • Benign brain tumors in family (OR 4.5) 6
  • Breast cancer in younger patients (<50 years) 6
  • Thyroid cancer or leukemia 3

Specific Genetic Syndromes to Consider

BAP1 and SMARCE1 mutations:

• Can occur with germline variants causing familial meningiomas 1
• Relevant family history and/or young age should prompt genetic counseling 1
• BAP1 is associated with rhabdoid/papillary meningiomas 1
• SMARCE1 is associated with clear cell meningiomas, particularly in cerebellopontine angle/spine 1, 7

Other hereditary syndromes with meningioma risk:

• Gorlin syndrome (nevoid basal cell carcinoma syndrome) 5
• PTEN Hamartoma Tumor Syndrome/Cowden Syndrome 7
• Werner Syndrome 7
• Rubinstein-Taybi syndrome 5

Radiation-Associated Family History

Particularly notable:

• Family members with meningiomas who had prior cranial radiation 5
• Multiple family members with cancers in irradiated sites (head, neck, chest) 8
• 11% of radiation-associated meningioma patients have additional first-degree relatives with meningioma, compared to only 1% in other groups 8
• This suggests genetic susceptibility increases meningioma risk after radiation exposure 8

Clinical Action Points

When family history is notable:

1. Document both maternal and paternal lineages 4

2. Record for each affected relative:

   • Type of primary tumor
   • Age at diagnosis
   • Any known genetic testing results 4

3. Consider genetic counseling referral when:

   • Meningioma diagnosed at <25 years 2
   • Multiple first-degree relatives affected 3
   • Associated syndromic features present 1, 7
   • Clear cell, rhabdoid, or papillary histology 1

4. Germline testing may be indicated for:

   • BAP1, SMARCE1, NF2, PTEN, and other relevant genes based on clinical presentation 1, 7

Important Caveats

• Familial meningiomas without underlying genetic syndrome are rare but documented 5
• Most sporadic meningiomas occur without significant family history 9
• The absence of family history does not exclude hereditary predisposition, as penetrance varies and family size/knowledge may be limited
• Radiation-induced meningiomas may cluster in families due to shared genetic susceptibility to radiation effects 8